Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-05-30
2006-05-30
Harris, Alana M. (Department: 1643)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S012200, C514S014800, C514S017400, C514S018700, C514S015800, C530S300000, C530S324000, C530S326000, C530S330000, C530S350000
Reexamination Certificate
active
07053058
ABSTRACT:
The invention provides pharmaceutical compositions and method for inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia (BPH). In one embodiment the pharmaceutical composition includes human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof. In another embodiment, the pharmaceutical composition includes a mixture of human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof and an anticancer drug which may be administered in an appropriate dosage form, dosage quantity and dosage regimen to a patient suffering from, for example of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, benign prostate hyperplasia, or (BPH) gastrointestinal cancer. The anticancer drug of the latter mixture may be one selected from the group of drugs including mitomycin, idarubicin, cisplatin, 5-fluoro-uracil, methotrexate, adriamycin, daunomycin, taxol, taxol derivative, and mixtures thereof.
REFERENCES:
patent: 5428011 (1995-06-01), Seth et al.
patent: 5994298 (1999-11-01), Tsai et al.
patent: 6319894 (2001-11-01), Tracey et al.
Bowie et al, Science, 247: 1306-1310, 1990.
Burgess et al, J. Cell Biology, 111: 2129-2138, 1990.
Lazar et al, Molecular and Cellular Biology, 8: 1247-1252, 1988.
Nolet, S. et al., Biochimica et Biohysica Acta, 1089: 247-249, 1991.
Xuan, J.W. et al., DNA & Cell Biology, 16: 627-638, 1997.
Xuan, J.W. et al, Journal of Cellular Biochemistry 65: 172-185, 1997.
Xuan, J.W., et al., J. Cell. Biochem., vol. 63, pp. 61-73, 1996.
Linard, C.G., et al., vol. 73, pp. 479-488, 1988.
Baijal-Gupta, M., et al., J. Endocrinology, vol. 165, pp. 425-433, 2000.
Garde, S.V., et al., Prostate, vol. 38, pp. 118-125, 1999.
Kele, P., et al., 26th European Peptide Symposium, J. Pept. Sci., vol. 6, Abstract S172, 2000.
Mbikay, M., et al. (DNA 6(1):23-29, 1987 (Gene Bank Accession No. AAA36635).
Makinen, M., et al. (Eur. J. Biochem. 264(2):407-414, 1999 (Gene Bank Accession No. CAB39325).
Akiyama, K., et al., Nippon Hoigaku Zasshi 39(2), pp. 181-186, 1985 (Gene Bank Accession No. 1209281A).
Baijal-Gupta Madhulika
Fraser Jennifer
Garde Seema
Kadhim Salam
Panchal Chandra
Fay Sharpe Fagan Minnich & McKee LLP
Harris Alana M.
Holleran Anne L.
Procyon Biopharma Inc.
LandOfFree
Pharmaceutical preparations and methods for inhibiting tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical preparations and methods for inhibiting tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical preparations and methods for inhibiting tumors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3589602